MKRN1 and colorectal carcinoma: Additionally, the R2 Genome Analysis Platform (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi) study revealed that patients with CRC with high MKRN1 expression levels had significantly shorter overall survival than those with low MKRN1 expression levels (Fig. 1E, P < 0.001).